COVID-19 Treatments

Left image

Getting Treatments

http://cdph-default/Programs/CID/DCDC/PublishingImages/COVID-19/woman-buying-medicine-at-pharmacy.png, Woman buys medicine at the pharmacy from a pharmacist.

1

If you have COVID-19 symptoms, talk to a health care provider right away to explore your options for treatment. The COVID-19 Treatment site can guide you to a resource that will help you get the right care to prevent you from developing serious illness.

https://covid19.ca.gov/treatment/, Find Free Treatments

Image

Treatment Information for Health Care Professionals		Treatment Information for Health Care Professionals		http://cdph-default/Programs/CID/DCDC/Pages/COVID-19/Treatment-Resources-for-Providers.aspx, Learn More	http://cdph-default/Programs/CID/DCDC/PublishingImages/icon-grid-document.png, document	#EB6E1F
COVID-19 Therapeutics Warmline		COVID-19 Therapeutics Warmline		http://cdph-default/Programs/CID/DCDC/CDPH%20Document%20Library/COVID-19/COVID-19-Therapeutics-Warmline-Flyer.pdf, Get Help	http://cdph-default/Programs/CID/DCDC/PublishingImages/Icon%20Grid/icon-faq.png, /Programs/CID/DCDC/PublishingImages/icon-grid-document.png	#2E8540

cont

ent

How to Use Telehealth

Right image

How to Use Telehealth

http://cdph-default/Programs/CID/DCDC/PublishingImages/COVID-19/man-talks-to-doctor-via-tablet.png, Male patient talks to a doctor on a tablet from home

1

Learn about how you can talk to a health care provider from home using your phone or video call.

http://cdph-default/Programs/CID/DCDC/Pages/COVID-19/treatments-telehealth.aspx, Read More

Image

COVID-19 Treatments Communications Toolkit

Left image

COVID-19 Treatments Communications Toolkit

http://cdph-default/Programs/OPA/PublishingImages/Toolkits/treatment/covid19treatments_01.png, Toolbox with caption "We have the tools to stop COVID-19. "

1

Share this collection of social media graphics and captions to increase awareness about COVID-19 treatment options.

http://cdph-default/Programs/OPA/Pages/Communications-Toolkits/COVID-19-Treatments.aspx, Get the Toolkit

Image

Treatment Resources

158

Treatment Resources

<ul><li><a href="/Programs/CID/DCDC/Pages/COVID-19/GuidanceForHospitalsRegardingAllocationOfScarceMedicationsForCOVID19.aspx" target="_blank" rel="noreferrer noopener" title="Allocation of Scarce Medications for Hospitals Guidance">Allocation of Scarce Medications for Hospitals Guidance </a> 5/11/2020 </li><li> <a href="https://www.phe.gov/emergency/events/COVID19/therapeutics/Pages/default.aspx" title="Health and Human Services (HHS) ASPR Preparedness & Response - COVID-19" target="_blank">Health and Human Services (HHS) ASPR Preparedness & Response - COVID-19</a></li><li> <a href="https://combatcovid.hhs.gov/" target="_blank">Health and Human Services (HHS) Combat COVID</a></li><li> <a href="https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/" target="_blank" rel="noreferrer noopener" title="Infection Disease Society of America (IDSA) Treatment Guidelines">Infection Disease Society of America (IDSA) Treatment Guidelines</a></li><li> <a href="/Programs/CID/DCDC/Pages/COVID-19/Test-to-treat-locations.aspx">Test to Treat Locations</a> 6/16/2022</li><li> <a href="https://www.covid19treatmentguidelines.nih.gov/?utm_campaign=+51131809&utm_content=&utm_medium=email&utm_source=govdelivery&utm_term=" title="The National Institutes of Health (NIH) COVID-19 Treatment Guidelines " target="_blank">The National Institutes of Health (NIH) COVID-19 Treatment Guidelines </a></li></ul><div><div class="ListContainerWrapper SCXW122577788 BCX0" style="margin:0px;padding:0px;"><ul class="BulletListStyle1 SCXW122577788 BCX0" role="list" style="margin:0px;padding:0px;overflow:visible;cursor:text;font-family:verdana;"><li data-leveltext="" data-font="Symbol" data-listid="2" aria-setsize="-1" data-aria-posinset="2" role="listitem" data-aria-level="1" class="OutlineElement Ltr BCX0 SCXW122577788" style="margin:0px 0px 0px 24px;padding:0px;overflow:visible;cursor:text;clear:both;direction:ltr;display:block;vertical-align:baseline;"> <span data-contrast="auto" lang="EN-US" class="TextRun EmptyTextRun SCXW122577788 BCX0 ms-rteFontSize-3" style="margin:0px;padding:0px;line-height:18px;font-family:calibri, calibri_embeddedfont, calibri_msfontservice, sans-serif;"></li><li data-leveltext="" data-font="Symbol" data-listid="2" aria-setsize="-1" data-aria-posinset="3" role="listitem" data-aria-level="1" class="OutlineElement Ltr SCXW122577788 BCX0" style="margin:0px 0px 0px 24px;padding:0px;overflow:visible;cursor:text;clear:both;direction:ltr;display:block;vertical-align:baseline;"> <span data-contrast="auto" lang="EN-US" class="TextRun EmptyTextRun SCXW122577788 BCX0 ms-rteFontSize-3" style="margin:0px;padding:0px;line-height:21px;font-family:calibri, calibri_embeddedfont, calibri_msfontservice, sans-serif;"></li></ul><ul class="BulletListStyle1 SCXW122577788 BCX0" role="list" style="margin:0px;padding:0px;overflow:visible;cursor:text;font-family:verdana;"><li data-leveltext="" data-font="Symbol" data-listid="2" aria-setsize="-1" data-aria-posinset="4" role="listitem" data-aria-level="1" class="OutlineElement Ltr SCXW122577788 BCX0" style="margin:0px 0px 0px 24px;padding:0px;overflow:visible;cursor:text;clear:both;direction:ltr;display:block;vertical-align:baseline;"> <span data-contrast="auto" lang="EN-US" class="TextRun EmptyTextRun SCXW122577788 BCX0 ms-rteFontSize-3" style="margin:0px;padding:0px;line-height:21px;font-family:calibri, calibri_embeddedfont, calibri_msfontservice, sans-serif;"></li><li data-leveltext="" data-font="Symbol" data-listid="2" aria-setsize="-1" data-aria-posinset="5" role="listitem" data-aria-level="1" class="OutlineElement Ltr SCXW122577788 BCX0" style="margin:0px 0px 0px 24px;padding:0px;overflow:visible;cursor:text;clear:both;direction:ltr;display:block;vertical-align:baseline;"> <span data-contrast="auto" lang="EN-US" class="TextRun EmptyTextRun SCXW122577788 BCX0 ms-rteFontSize-3" style="margin:0px;padding:0px;line-height:21px;font-family:calibri, calibri_embeddedfont, calibri_msfontservice, sans-serif;"></li></ul></div></div><div><div class="ListContainerWrapper SCXW122577788 BCX0" style="margin:0px;padding:0px;"><ul class="BulletListStyle1 SCXW122577788 BCX0" role="list" style="margin:0px;padding:0px;overflow:visible;cursor:text;font-family:verdana;"><li data-leveltext="" data-font="Symbol" data-listid="2" aria-setsize="-1" data-aria-posinset="1" role="listitem" data-aria-level="1" class="OutlineElement Ltr SCXW122577788 BCX0" style="margin:0px 0px 0px 24px;padding:0px;overflow:visible;cursor:text;clear:both;direction:ltr;display:block;vertical-align:baseline;"> <span data-contrast="auto" lang="EN-US" class="TextRun EmptyTextRun SCXW122577788 BCX0 ms-rteFontSize-3" style="margin:0px;padding:0px;line-height:18px;font-family:calibri, calibri_embeddedfont, calibri_msfontservice, sans-serif;"></li><li data-leveltext="" data-font="Symbol" data-listid="2" aria-setsize="-1" data-aria-posinset="2" role="listitem" data-aria-level="1" class="OutlineElement Ltr SCXW122577788 BCX0" style="margin:0px 0px 0px 24px;padding:0px;overflow:visible;cursor:text;clear:both;direction:ltr;display:block;vertical-align:baseline;"> <span data-contrast="auto" lang="EN-US" class="TextRun EmptyTextRun SCXW122577788 BCX0 ms-rteFontSize-3" style="margin:0px;padding:0px;line-height:21px;font-family:calibri, calibri_embeddedfont, calibri_msfontservice, sans-serif;"></li></ul><ul class="BulletListStyle1 SCXW122577788 BCX0" role="list" style="margin:0px;padding:0px;overflow:visible;cursor:text;font-family:verdana;"><li data-leveltext="" data-font="Symbol" data-listid="2" aria-setsize="-1" data-aria-posinset="3" role="listitem" data-aria-level="1" class="OutlineElement Ltr SCXW122577788 BCX0" style="margin:0px 0px 0px 24px;padding:0px;overflow:visible;cursor:text;clear:both;direction:ltr;display:block;vertical-align:baseline;"> <span data-contrast="auto" lang="EN-US" class="TextRun EmptyTextRun SCXW122577788 BCX0 ms-rteFontSize-3" style="margin:0px;padding:0px;line-height:21px;font-family:calibri, calibri_embeddedfont, calibri_msfontservice, sans-serif;"></li><li data-leveltext="" data-font="Symbol" data-listid="2" aria-setsize="-1" data-aria-posinset="4" role="listitem" data-aria-level="1" class="OutlineElement Ltr SCXW122577788 BCX0" style="margin:0px 0px 0px 24px;padding:0px;overflow:visible;cursor:text;clear:both;direction:ltr;display:block;font-family:"times new roman", "times new roman_msfontservice", serif;vertical-align:baseline;"> <span data-contrast="auto" lang="EN-US" class="TextRun EmptyTextRun SCXW122577788 BCX0 ms-rteFontSize-3" style="margin:0px;padding:0px;line-height:18px;font-family:calibri, calibri_embeddedfont, calibri_msfontservice, sans-serif;"></li></ul><ul class="BulletListStyle1 SCXW122577788 BCX0" role="list" style="margin:0px;padding:0px;overflow:visible;cursor:text;font-family:verdana;"><li data-leveltext="" data-font="Symbol" data-listid="2" aria-setsize="-1" data-aria-posinset="5" role="listitem" data-aria-level="1" class="OutlineElement Ltr SCXW122577788 BCX0" style="margin:0px 0px 0px 24px;padding:0px;overflow:visible;cursor:text;clear:both;direction:ltr;display:block;font-family:"times new roman", "times new roman_msfontservice", serif;vertical-align:baseline;"> <span data-contrast="auto" lang="EN-US" class="TextRun EmptyTextRun SCXW122577788 BCX0 ms-rteFontSize-3" style="margin:0px;padding:0px;line-height:18px;font-family:calibri, calibri_embeddedfont, calibri_msfontservice, sans-serif;"></li></ul></div></div><div><div class="ListContainerWrapper SCXW122577788 BCX0" style="margin:0px;padding:0px;"><ul class="BulletListStyle1 SCXW122577788 BCX0" role="list" style="margin:0px;padding:0px;overflow:visible;cursor:text;font-family:verdana;"><li data-leveltext="" data-font="Symbol" data-listid="2" aria-setsize="-1" data-aria-posinset="1" role="listitem" data-aria-level="1" class="OutlineElement Ltr SCXW122577788 BCX0" style="margin:0px 0px 0px 24px;padding:0px;overflow:visible;cursor:text;clear:both;direction:ltr;display:block;font-family:"times new roman", "times new roman_msfontservice", serif;vertical-align:baseline;"> <span data-contrast="auto" lang="EN-US" class="TextRun EmptyTextRun SCXW122577788 BCX0 ms-rteFontSize-3" style="margin:0px;padding:0px;line-height:18px;font-family:calibri, calibri_embeddedfont, calibri_msfontservice, sans-serif;"></li></ul></div></div>

https://www.cdph.ca.gov/Programs/CID/DCDC/Lists/covid19TrendingTopics/DispForm.aspx?ID=40	Distribution & Ordering: Anti-SARS-CoV-2 Therapeutics	http://cdph-default/Programs/CID/DCDC/Pages/COVID-19/COVID-19-Treatments-Distribution-and-Ordering.aspx, Get the Guidance	http://cdph-default/Programs/CID/DCDC/PublishingImages/COVID-19/pharmacy-counter.png, Pharmacy shelves
https://www.cdph.ca.gov/Programs/CID/DCDC/Lists/covid19TrendingTopics/DispForm.aspx?ID=41	How to Become a Test to Treat Site	http://cdph-default/Programs/CID/DCDC/Pages/COVID-19/Become-Test-to-Treat-Site.aspx, Learn More	http://cdph-default/Programs/CID/DCDC/PublishingImages/COVID-19/pharmacist-explains-meds-to-patient.png, Pharmacist explains medicine details to a patient
https://www.cdph.ca.gov/Programs/CID/DCDC/Lists/covid19TrendingTopics/DispForm.aspx?ID=42	NIH Statement on Outpatient Therapies	https://www.covid19treatmentguidelines.nih.gov/management/clinical-management/nonhospitalized-adults--therapeutic-management/, See the Statement	http://cdph-default/Programs/CID/DCDC/PublishingImages/COVID-19/hand-organizing-medicine.png, Pharmacist organizes medicine
https://www.cdph.ca.gov/Programs/CID/DCDC/Lists/covid19TrendingTopics/DispForm.aspx?ID=43	Revisions to Evusheld Dosing	https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-evusheld-dosing, Read the Revisions	http://cdph-default/Programs/CID/DCDC/PublishingImages/COVID-19/pharmacist-preparing-meds.png, Pharmacist prepares medicine

COVID-19

Diseases and Conditions

Licensing, Certification and Other Credentials

Family Health

Personal Health and Prevention

Health and Safety

Health Facilities

Administrative

Person Interested In

COVID-19 Treatments